Continental Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Continental Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.73M	Sell	75,754 -3,000	-4%	-$190K	2.02%	20
2026 Q2	$4.54M	Buy	78,754 +9,000	+13%	+$517K	1.92%	21
2026 Q1	$4.23M	Sell	69,754 -5,000	-7%	-$291K	2.16%	17
2025 Q4	$4.03M	Buy	+74,754	New	+$3.6M	1.7%	19
2014 Q1	–	Sell	-17,500	Closed	-$930K	–	131
2013 Q4	$930K	Sell	17,500 -12,500	-42%	-$637K	0.2%	104
2013 Q3	$1.39M	Hold	30,000	–	–	0.34%	78
2013 Q2	$1.34M	Buy	+30,000	New	+$1.3M	0.38%	74

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Continental Advisors's BMY Position: Q3 2026 in Review

Continental Advisors reduced its Bristol-Myers Squibb (BMY) stake by 3.8% in Q3 2026, selling an estimated $190K and leaving 75,754 shares worth $4.73M. The position accounts for 2.02% of the portfolio, ranked #20.

Continental Advisors first reported a position in BMY in Q2 2013 and has held it in 7 quarters since. 563 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Continental Advisors held 75,754 shares of Bristol-Myers Squibb worth $4.73M as of Q3 2026.
Continental Advisors sold 3,000 Bristol-Myers Squibb shares in Q3 2026, an estimated $190K.
Bristol-Myers Squibb made up 2.02% of Continental Advisors's portfolio in Q3 2026, its #20 holding.
Continental Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 7 quarters since.
563 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Continental Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.